» Articles » PMID: 19209282

Effectiveness of Twice Daily Azelastine Nasal Spray in Patients with Seasonal Allergic Rhinitis

Overview
Publisher Dove Medical Press
Date 2009 Feb 12
PMID 19209282
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Azelastine nasal spray (Allergodil((R)), Lastin((R)), Afluon((R)); Meda AB, Stockholm, Sweden) is a fast-acting, efficacious and well-tolerated H1-receptor antagonist for the treatment of rhinitis. In addition it also has mast-cell stabilizing and anti-inflammatory properties, reducing the concentration of leukotrienes, kinins and platelet activating factor in vitro and in vivo, as well as inflammatory cell migration in rhinitis patients. Well-controlled studies in patients with seasonal allergic rhinitis (SAR), perennial rhinitis (PR) or vasomotor rhinitis (VMR) confirm that azelastine nasal spray has a rapid onset of action, and improves nasal symptoms associated with rhinitis such as nasal congestion and post-nasal drip. Azelastine nasal spray is effective at the lower dose of 1 spray as well at a dose of 2 sprays per nostril twice daily, but with an improved tolerability profile compared to the 2-spray per nostril twice daily regimen. Compared with intranasal corticosteroids, azelastine nasal spray has a faster onset of action and a better safety profile, showing at least comparable efficacy with fluticasone propionate (Flonase((R)); GSK, USA), and a superior efficacy to mometasone furoate (Nasonex((R)); Schering Plough, USA). In combination with fluticasone propionate, azelastine nasal spray exhibits greater efficacy than either agent used alone, and this combination may provide benefit for patients with difficult to treat seasonal allergic rhinitis. In addition, azelastine nasal spray can be used on an as-needed basis without compromising clinical efficacy. Compared with oral antihistamines, azelastine nasal spray also demonstrates superior efficacy and a more rapid onset of action, and is effective even in patients who did not respond to previous oral antihistamine therapy. Unlike most oral antihistamines, azelastine nasal spray is effective in alleviating nasal congestion, a particularly bothersome symptom for rhinitis sufferers. Azelastine nasal spray is well tolerated in both adults and children with allergic rhinitis. Bitter taste which seems to be associated with incorrect dosing technique is the most common side effect reported by patients, but this problem can be minimized by correct dosing technique.

Citing Articles

Validated HPLC method for simultaneous determination of azelastine hydrochloride fluticasone propionate and oxymetazoline in nasal mucosa and nasopharyngeal swabs from real human samples.

Mikawy N, Magdy N, Mohamed M, El-Kosasy A Sci Rep. 2025; 15(1):4252.

PMID: 39905047 PMC: 11794526. DOI: 10.1038/s41598-024-82387-7.


Cytological Study of Topical Effect of Azelastine Hydrochloride on the Nasal Mucous Membrane Cells in Various Nasal Rhinitis Types.

Trybus E, Trybus W, Krol T Cells. 2023; 12(23).

PMID: 38067125 PMC: 10706206. DOI: 10.3390/cells12232697.


A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis.

Bousquet J, Klimek L, Kuhl H, Nguyen D, Ramalingam R, Canonica G Front Allergy. 2023; 4:1244012.

PMID: 37920410 PMC: 10619846. DOI: 10.3389/falgy.2023.1244012.


Fluticasone Propionate with Azelastine Versus Standalone Fluticasone Propionate as Nasal Spray in Allergic Rhinitis: A Prospective Comparative Study in a Rural Population of Northern India.

Agrawal A, Shubhanshu K, Ahmad M Indian J Otolaryngol Head Neck Surg. 2023; 75(3):2168-2171.

PMID: 37636743 PMC: 10447315. DOI: 10.1007/s12070-023-03856-5.


Comparison of the Effects of Azelastine and Fluticasone Nasal Sprays in the Treatment of Allergic Rhinitis.

Krishnakumar D, Faizal B, Nair A Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):1632-1637.

PMID: 36452604 PMC: 9702036. DOI: 10.1007/s12070-021-02686-7.


References
1.
Falser N, WOBER W, Rahlfs V, Baehre M . Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001; 51(5):387-93. DOI: 10.1055/s-0031-1300052. View

2.
Thomas K, Ollier S, Ferguson H, Davies R . The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen. Clin Exp Allergy. 1992; 22(6):642-7. DOI: 10.1111/j.1365-2222.1992.tb00182.x. View

3.
Shinoda M, Watanabe N, Suko T, MOGI G, Takeyama M . Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions. Am J Rhinol. 1997; 11(3):237-41. DOI: 10.2500/105065897781751901. View

4.
Ito H, Nakamura Y, Takagi S, Sakai K . Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy. Arzneimittelforschung. 1999; 48(12):1143-7. View

5.
Weiner J, Abramson M, Puy R . Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998; 317(7173):1624-9. PMC: 28740. DOI: 10.1136/bmj.317.7173.1624. View